MASI DINA (Chief Financial Officer) received a stock award from INTEGRATED BIOPHARMA INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/21/2023ACC: 0001345281-23-000004
Officer· Chief Financial Officer
Since May 2019
0.00
Net shares
Net seller
$4.5K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
50K acquired · 50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
$0.09
Trade value
$4.50K
% of position
51.4%
9/20/2023
97.20K→147.20K
Total
Net shares
+50K
Net value
$4.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/20/2023 | A · Award | +50K | $0.09 | $4.50K | 51.4% | 97.20K | 147.20K |
| Total | +50K | $4.50K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
0.09
Held after
576.67K
Exercisable
—
9/20/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock50K shares | 9/20/2023 | D · Disposition | −50K | 0.09 | — | 576.67K |